ReviewInternational journal of molecular sciences2026

Targeting MET in 2025: From Exon 14 Skipping to MET-Amplified Acquired Resistance in Non-Small Cell Lung Cancer.

Aliya Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.